FDA advisers say new Alzheimer’s drug lecanemab slows cognitive decline | US healthcare | The Guardian

FDA advisers say new Alzheimer’s drug lecanemab slows cognitive decline | US healthcare | The Guardian submitted by /u/chilladipa
[link] [comments]

Adding genomic info to blood biomarkers yields cost-effective results for chronic disease prevention: Study

Adding genomic info to blood biomarkers yields cost-effective results for chronic disease prevention: Study The researchers used machine learning to build predictive models for individuals' future risks of nine common diseases, based on their genetic information and the biomarkers that they measured. https://ift.tt/WOPVC01

U.S. government sets penalties on 43 drugs over price hikes

Drugmakers hiked the price of these 43 drugs by more than the rate of inflation and are required to pay the difference of those medicines to Medicare, the federal health program for Americans over age 65.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/st0lWEH
via gqrds

U.S. government sets penalties on 43 drugs over price hikes

U.S. government sets penalties on 43 drugs over price hikes Drugmakers hiked the price of these 43 drugs by more than the rate of inflation and are required to pay the difference of those medicines to Medicare, the federal health program for Americans over age 65. https://ift.tt/0NfGR1m

2022 was the worst year on record for attacks on health care workers

2022 was the worst year on record for attacks on health care workers submitted by /u/Maxcactus
[link] [comments]

India logs 186 fresh COVID cases

India logs 186 fresh COVID cases The number of people who have recuperated from the disease has increased to 4,44,58,259, while the case fatality rate has been recorded at 1.18 per cent. https://ift.tt/0NfGR1m

US FDA panel backs approval for Eisai-Biogen Alzheimer's drug Leqembi

US FDA panel backs approval for Eisai-Biogen Alzheimer's drug Leqembi Leqembi won accelerated approval by the FDA in January based on its ability to remove sticky amyloid plaques from the brain. The panel on Friday considered Eisai's large confirmatory trial designed to show the drug benefited patients. https://ift.tt/0NfGR1m